Raising Orphans: How Clinical Development Programs of Drugs for Rare and Common Diseases Are Different

E-ISSN： 1532-6535|92|2|262-264

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.92, Iss.2, 2012-08, pp. : 262-264

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Academic Institutions in the Development of Drugs for Rare and Neglected Diseases

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 92, Iss. 2, 2012-08 ,pp. : 193-202

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rare Diseases and Orphan Drugs: A comprehensive approach of strategic perspectives

By Hansen Jan-C閐ric

Journal of Communication In Healthcare, Vol. 5, Iss. 4, 2012-12 ,pp. : 199-219

Maney Publishing

Access to resources Recommend Favorite

Raising achievement: educating physicians to address effects of at-risk drinking on common diseases

By Gannon Meghan A Qaseem Amir Snow Vincenza Turner Barbara

Quality in Primary Care, Vol. 19, Iss. 1, 2011-02 ,pp. : 43-47

Radcliffe Press

Access to resources Recommend Favorite

A model for collaborative clinical research in rare diseases: experience from the Rare Disease Clinical Research Network program

By Groft Stephen C Gopal-Srivastava Rashmi

Clinical Investigation, Vol. 3, Iss. 11, 2013-11 ,pp. : 1015-1021

Future Science

Access to resources Recommend Favorite

Drugs in Clinical Development for Chronic Obstructive Pulmonary Disease

Respiration, Vol. 72, Iss. 1, 2005-02 ,pp. : 105-112

Karger

Access to resources Recommend Favorite